On the basis of these data and the known function of YB-1 in the regulation of erbB1 and erbB2 expression [7,8], it can be assumed that exposure of tumor cells to IR as it occurs during conventional radiotherapy may lead to an enhanced expression of erbB1 and erbB2. The gene discussed is YBX1; the disease is neoplasm.